Global Astigmatism Market Size, Share, and COVID-19 Impact Analysis, By Type (Myopic Astigmatism, Hyperopic Astigmatism, and Others), By Treatment (Corrective Lenses, Orthokeratology {Ortho-K}, Surgeries and Others), By End User (Hospital, Clinics, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032

Industry: Healthcare


Global Astigmatism Market Insights Forecasts to 2030

  • The Global Astigmatism Market Size was valued at USD 1.8 Billion in 2022.
  • The Market is growing at a CAGR of 5.2% from 2022 to 2032.
  • The Worldwide Astigmatism Market size is expected to reach USD 3.1 Billion by 2032.
  • Europe is expected to grow the fastest during the forecast period.

Global Astigmatism Market

Get more details on this report -

Request Free Sample PDF


The Global Astigmatism Market Size is expected to reach USD 3.1 Billion by 2032, at a CAGR of 5.2% during the forecast period 2022 to 2032. The Asia Pacific region is inhabited by developing nations including China, India, Indonesia, Malaysia, and Thailand, among others. These nations are expanding quickly as a result of increased urbanization, population, and disposable income levels.


 Market Overview

Astigmatism is a type of vision or eyesight issue that typically results from an imperfection in the shape of the cornea. It can also happen as a result of the lens's internal curvature or an unevenly shaped cornea (the clear front surface of the eye). Along with other refractive abnormalities, astigmatism can occur in people. These mistakes may include things like hyperopia (farsightedness) or myopia (near-sightedness). Typically, astigmatism can be treated with eyeglasses, contact lenses, or surgery. The cornea of the eye is likely to be formed erratically in a person who has astigmatism. When the curve of the lens inside the eye is uneven, astigmatism is more likely to develop. If someone is receiving therapy for astigmatism, the patient will be given glasses or a contact lens that changes how light enters the eye. Due to growing awareness of eye care needs and associated requirements, the treatment for astigmatism is also experiencing a growing trend. Blurred vision is a symptom of astigmatism, which may be treated with a variety of methods, making it an accessible and reasonably priced choice.


Report Coverage

This research report categorizes the global astigmatism market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global astigmatism market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the global astigmatism market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.



Global Astigmatism Market Report Coverage

Report CoverageDetails
Base Year:2022
Market Size in 2022:USD 1.8 Billion
Historical Data for:2018-2021
No. of Pages:200
Tables, Charts & Figures:100
Segments covered:By Type, By Treatment, By End User, By Region, COVID-19 Impact Analysis
Companies Covered: Novartis AG, SEA VISION S.r.l.,  Johnson & Johnson Services, Inc.,  Bauch and Lomb, CooperVision, Carl Zeiss Meditec AG, Seed Co., Ltd.,  Essilor Group, Menicon Co., Ltd., Benq Materials Corporation
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF

Driving Factors

The rising prevalence of visual impairments around the world is driving the demand for astigmatism treatment. Also, the rising occurrence of corneal abnormalities is boosting the astigmatism treatment market. Moreover, technological advancements in the field of ophthalmology are helping to improve the diagnosis and treatment of astigmatism. In addition, the increased awareness and education about the causes and effects of astigmatism are driving demand for treatment options. Patients are becoming more aware of the symptoms and risks associated with the condition, which is leading to increased demand for treatment. The availability of a wide range of treatment options for astigmatism, such as corrective lenses, surgery, and medication, is driving the growth of the market. Patients have more choices than ever before when it comes to treating their condition, which is contributing to market growth. Moreover, the rising healthcare expenditure and growing demand for quality healthcare services are driving the growth of the astigmatism market. Patients are willing to spend more on treatments that can provide them with better vision and quality of life.


Restraining Factors

Several restraining factors could affect market growth, including, the cost of treatment for astigmatism can be high, especially for advanced treatment options such as LASIK surgery or toric lenses. This can limit access to treatment for many patients, particularly in low- and middle-income countries. While there are several treatment options available for astigmatism, some patients may not be suitable candidates for certain treatments. This can limit the availability of treatment options and limit the market growth. Also, there are alternative treatments available for vision correction, such as contact lenses or glasses, which may limit the growth of the astigmatism market.


Market Segmentation

In 2022, the myopic astigmatism segment is dominate the market with the largest market share during the forecast period.

Based on the type, the global astigmatism market is bifurcated into myopic astigmatism, hyperopic astigmatism, and others. Among these, the myopic astigmatism segment is projecting significant growth owing to the incidence of astigmatism accompanied by myopia. Moreover, advancements in technology have led to the development of new treatment options for myopic astigmatisms, such as LASIK surgery and toric lenses, which are driving the growth of the market.


In 2022, the corrective lenses segment is driving the largest market share over the forecast period.

On the basis of treatment, the global astigmatism market is classified into corrective lenses, orthokeratology {ortho-k}, surgeries, and others. Among these, corrective lenses segment are holding the largest market during the forecast period, owing to the rising use of these lenses by astigmatic people and others who want to enhance their appearance is responsible for global growth. Furthermore, corrective lenses provide a non-invasive and non-surgical option for treating astigmatism, and they are widely available at affordable prices.


In 2022, the clinics segment is influencing the market share growth during the forecast period.

Based on the end users, the global astigmatism market is segmented into hospitals, clinics, and others. Among these, the clinics segment is expected to grow the market during the forecast period. This is due to the rising demand for outpatient care and the availability of advanced diagnostic and treatment options in clinics. Clinics provide a convenient and accessible option for patients to receive diagnosis and treatment for astigmatism, as well as other vision-related issues.


Regional Segment Analysis of the astigmatism market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)


North America is dominating the market with the largest market share over the forecast period


Astigmatism Market

Get more details on this report -

Request Free Sample PDF


North America is dominating the market growth of the global astigmatism market due to the growing geriatric population, and the presence of a well-developed healthcare industry. Also, with the rising prevalence of astigmatism among the adult and elderly population, the astigmatism market is likely to be expanding in the North American region.


Europe region is projected to acquire the second-largest share in the global market premises, owing to the presence of major players, the high awareness of astigmatism, and the extensive research and development activities present in this region. Moreover, the well-developed healthcare and pharmaceutical sector may grow their market share during the forecast period.


Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the global astigmatism market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.


List of Key Companies

  • Novartis AG
  • SEA VISION S.r.l.
  • Johnson & Johnson Services, Inc.
  • Bauch and Lomb
  • CooperVision
  • Carl Zeiss Meditec AG
  • Seed Co., Ltd.
  • Essilor Group
  • Menicon Co., Ltd.
  • Benq Materials Corporation


Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)


Recent Development

  • In January 2018, The US launch of enhanced parameters for 1-Day Acuvue Moist brand astigmatism contact lenses has been announced by Johnson & Johnson, another significant market participant. These lenses contain daily disposable functionality and a blink-stabilized construction for stable and clear vision.


Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global Astigmatism Market based on the below-mentioned segments:


Global Astigmatism Market, By Type

  • Myopic Astigmatism
  • Hyperopic Astigmatism
  • Others


Global Astigmatism Market, By Treatment

  • Corrective Lenses
  • Orthokeratology {Ortho-K}
  • Surgeries 
  • Others


Global Astigmatism Market, By End Users

  • Hospitals
  • Clinics
  • Others


Astigmatism Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies